pt141 fda approved PT-141 for Men and Women: Same Treatment, Different Results PT-141 Peptide Therapy for Enhanced

Glossary 3D-CRT Three-dimensional conformal radiation therapy AI Artificial intelligence AIs Aromatase inhibitors Anti-CTLA4 Anti-cytotoxic T-lymphocyte-associated antigen 4 antibody Anti-PD1 Anti-programmed cell death protein 1 APBI Accelerated partial breast irradiation ATM Ataxia-telangiectasia mutated gene BC Breast cancer BMX/STAT3 Bone marrow and X-linked nonreceptor tyrosine kinase/Signal transducer and activator of transcription 3 protein BPA Bisphenol A BRCA1 Breast cancer gene 1 BRCA2 Breast cancer gene 2 CAF Cancer-associated fibroblasts CDH1 Cadherin 1 CDK4/6 Cyclin-dependent kinases 4 and 6 CHEK2 Checkpoint kinase 2 CNN Convolution neural network CNV Copy number variation CR Circadian rhythm CSC Cancer stem cells CTC Circulating tumor cell ctDNA Circular tumor DNA CTL Cytotoxic T Lymphocyte DAVID Database for annotation, visualization and integrated discovery DDR1-mediated STAT1 Discoidin domain receptor 1-mediated Signal transducer and activator of transcription 1 DDT Dichlorodiphenyltrichloroethane DL Deep learning dsDNA Double-stranded DNA DTC Disseminated tumor cell EBRT External beam radiation therapy ECM Extra cellular matrix EDC Endocrine disrupting chemicals EGF Epidermal growth factor EMT Epithelial-mesenchymal transition ER Estrogen receptor ER+ Estrogen recptor positive EV extracellular vesicle exomiRs Exosomal microRNAs FAT1 Fat atypical cadherin 1 FNA Fine needle aspiration GPX4 Glutathione peroxidase 4 GRB2 Growth factor receptor-bound protein 2 GRN Gene regulatory network GSEA Gene set enrichment analysis GWAS Genome-wide association studies HER2 Human epidermal growth factor receptor HIF-1 Hypoxia inducible factor-1 HRT Hormone replacement therapy ICGC International cancer genome consortium ICI Immune checkpoint inhibitors IGF-1 Insulin-like growth factor-1 IHC Immunohistochemistry IMRT Intensity-modulated radiation therapy KEGG Kyoto encyclopedia of genes and genomes KK-LC-1 Kita-Kyushu lung cancer antigen-1 LAR Luminal androgen receptor LOX Lysyl oxidases LYNA Lymph node assistant MAPK Mitogen-activated protein kinase MDSC Myeloid-derived suppressor cell METABRIC Molecular taxonomy of breast cancer MHC Major histocompatibility complex ML Machine learning MMP Matrix metalloproteinases MRI Magnetic resonance imaging MSK-IMPACT Memorial sloan kettering-integrated mutation profiling of actionable cancer myCAF Myofibroblastic CAF NCI-CPTAC National cancer institute-clinical proteomic tumor analysis consortium NF-B Nuclear factor-kappa B NGS Next-generation sequencing NK Natural killer NLP Natural language processing NO2 Nitrogen dioxide PAH Polycyclic aromatic hydrocarbons PALB2 Partner and localizer of BRCA2 PARP Poly ADP ribose polymerase PCA Principal component analysis PCAWG Pan-cancer analysis of whole genome pCR Pathological complete response PDGF Platelet-derived growth factor PD-L1/PD Programmed death ligand 1/Programmed cell-death protein 1 PFAS Polyfluoroalkyl substances PI3K/AKT Phosphatidylinositol 3-kinase/protein kinase B PLC Phospholipase gamma PM Particulate matter POP Persistent organic pollutants PR Progesterone receptor PTEN Phosphatase and tensin homolog RANK Receptor activator of nuclear RCD Regulated cell death ROS Reactive oxygen species SASP Senescence-associated secretory phenotype SERM Selective estrogen receptor modulator SHC Src homolog and collagen homolog SNLB Sentinel lymph node biopsy STAT3 Signal transducer and activator of transcription 3 STK11 Serine/threonine kinase 1 STRING Search tool for the retrieval of interacting genes/proteins TAM Tumor-associated macrophages TCA Tricarboxylic acid TCGA The cancer genome atlas TGF- Transforming growth factor-beta TIL Tumor-infiltrating lymphocytes TMAO Trimethylamine N-oxide TME Tumer microenvironment TNBC Triple-negative breast cancer TNF- Tumor necrosis factor-alpha TP53 Tumor protein p53 Tregs Regulatory T cells TSG Tumor suppressor genes TSPAN8 Tetraspanin-8 VEGF Vascular endothelial growth factor WGCNA Weighted gene co-expression network analysis 51-FAK/Src Integrin 51 and Focal adhesion kinase/c-Src proto-oncogene

In a phase I trial, patients diagnosed with inflammatory breast cancer received glutamine during MTX neoadjuvant therapy in escalating doses for 3 weeks, followed by a doxorubicin-based regimen

Verywell Health

Sources Raun, K., et al

Pignocchi et al

doi: 10.1373/clinchem.2008.121269 132 FieldEHorstHMRubinfeldISCopelandCFWaheedUJordanJet al